Global Generic Drugs Market 2018-2022 - Key Vendors are Fresenius Kabi, Mylan, Novartis, Pfizer, Sun Pharmaceutical Industries & Teva Pharmaceutical Industries

DUBLIN, July 26, 2018 /PRNewswire/ --

The "Global Generic Drugs Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The Global Generic Drugs Market to grow at a CAGR of 10.22% during the period 2018-2022.

Global generic drugs market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend affecting this market is the rising M&A M&A in the generic drugs sector is likely to increase in the future due to increasing negotiations between companies. Rising drug shortages due to difficulties in acquiring raw materials, the shortage of raw materials, manufacturing problems, and regulatory issues will lead companies to strategically collaborate with one another to have a stronger presence in the market with combined resources.

According to the report, one driver influencing this market is the low-cost alternatives. Generic drugs are available at a lower cost compared with branded drugs as generic drug applicants do not have to repeat animal and clinical studies that were required to demonstrate the safety and effectiveness of brand-name medicines.

Further, the report states that one challenge affecting this market is the rising credibility issues. The global generic drugs market faces credibility issues in terms of the safety and quality of generic drugs. Increasing cases of substandard generic products being withdrawn from the market are also leading to credibility issues among patients.

Key vendors

    --  Fresenius Kabi
    --  Mylan
    --  Novartis
    --  Pfizer
    --  Sun Pharmaceutical Industries
    --  Teva Pharmaceutical Industries

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

    --  Market ecosystem
    --  Market characteristics
    --  Market segmentation analysis

PART 05: MARKET SIZING

    --  Market definition
    --  Market sizing 2017
    --  Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

    --  Bargaining power of buyers
    --  Bargaining power of suppliers
    --  Threat of new entrants
    --  Threat of substitutes
    --  Threat of rivalry
    --  Market condition

PART 07: MARKET SEGMENTATION BY END-USER

    --  Segmentation by end-user
    --  Comparison by end-user
    --  Pharmaceutical and biotechnology companies - Market size and forecast
        2017-2022
    --  Academic and research institutes - Market size and forecast 2017-2022
    --  CROs - Market size and forecast 2017-2022
    --  Market opportunity by end-user

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

    --  Geographical segmentation
    --  Regional comparison
    --  Americas - Market size and forecast 2017-2022
    --  EMEA - Market size and forecast 2017-2022
    --  APAC - Market size and forecast 2017-2022
    --  Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

    --  Market drivers
    --  Market challenges

PART 12: MARKET TRENDS

    --  Increasing focus on promotional activities
    --  Growth in outsourcing activities
    --  Increasing research activities in stem cells
    --  Technological advances

PART 13: VENDOR LANDSCAPE

    --  Overview
    --  Landscape disruption

PART 14: VENDOR ANALYSIS

    --  Vendors covered
    --  Vendor classification
    --  Market positioning of vendors

For more information about this report visit https://www.researchandmarkets.com/research/qkvdw6/global_generic?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-generic-drugs-market-2018-2022---key-vendors-are-fresenius-kabi-mylan-novartis-pfizer-sun-pharmaceutical-industries--teva-pharmaceutical-industries-300687100.html

SOURCE Research and Markets